Literature DB >> 18991494

The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme.

Mariska Sie1, Michiel Wagemakers, Grietje Molema, Jan Jakob A Mooij, Eveline S J M de Bont, Wilfred F A den Dunnen.   

Abstract

OBJECT: In the present study, the authors analyzed the ANGPT1/ANGPT2 balance in the context of therapeutic outcome in 62 patients with primary glioblastomas multiforme (GBMs).
METHODS: The tumor tissue used was obtained in adult patients who underwent neurosurgical debulking. Microvessel density was assessed by morphometric analysis. Double immunostaining for Ki 67/CD34 and cleaved caspase-3/CD34 was used to investigate the proliferation and apoptotic fraction of both endothelial and tumor cells. The expression of VEGFs (A-D) was evaluated on immunohistochemistry. To measure tumor vascular stabilization, the ANGPT1/ANGPT2 mRNA balance was determined using real-time reverse transcriptase polymerase chain reaction.
RESULTS: Within the hypoxic perinecrotic tumor area, the apoptotic fraction of endothelial cells was positively correlated with VEGFA expression (p < 0.001). Higher levels of VEGFA correlated with greater proliferation of endothelial cells in the intermediate tumor area (p = 0.031). Vascular endothelial growth factor D was significantly more highly expressed within the perinecrotic tumor area compared with the intermediate tumor area (p < 0.001). Multivariate analysis showed a significant association between the ANGPT1/ANGPT2 balance and the survival time of patients with GBMs (p = 0.035).
CONCLUSIONS: The results of the present study suggest that the ANGPT1/ANGPT2 balance has prognostic value in patients with primary GBMs. The authors' findings support the need for further studies of the feasibility of antiangiogenic therapy in primary GBMs, with a special focus on the normalization of tumor vasculature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18991494     DOI: 10.3171/2008.6.17612

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas.

Authors:  Sung-Suk Chae; Walid S Kamoun; Christian T Farrar; Nathaniel D Kirkpatrick; Elisabeth Niemeyer; Annemarie M A de Graaf; A Gregory Sorensen; Lance L Munn; Rakesh K Jain; Dai Fukumura
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

2.  Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617.

Authors:  Nikolett Molnar; Dietmar W Siemann
Journal:  Microvasc Res       Date:  2012-02-23       Impact factor: 3.514

Review 3.  Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.

Authors:  Nikolett M Biel; Dietmar W Siemann
Journal:  Cancer Lett       Date:  2014-10-12       Impact factor: 8.679

4.  Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.

Authors:  Ravindra Pramod Deshpande; Y B V K Chandra Sekhar; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

5.  Expression, purification and characterization of rat angiopoietin-2 in Pichia pastoris.

Authors:  Jinfeng Wang; Leilei Zhou; Xin Cai; Minji Zou; Yuanyuan Wang; Wenliang Fu; Jiaxi Wang; Donggang Xu
Journal:  Mol Biol Rep       Date:  2010-03-13       Impact factor: 2.316

6.  Induction of angiopoietin-2 after spinal cord injury.

Authors:  J C Durham-Lee; Y Wu; V U L Mokkapati; A A Paulucci-Holthauzen; O Nesic
Journal:  Neuroscience       Date:  2011-10-04       Impact factor: 3.590

7.  Identification of valid endogenous control genes for determining gene expression in human glioma.

Authors:  Simone Kreth; Jens Heyn; Stefan Grau; Hans A Kretzschmar; Rupert Egensperger; Friedrich W Kreth
Journal:  Neuro Oncol       Date:  2010-02-05       Impact factor: 12.300

Review 8.  Combining drugs and radiotherapy: from the bench to the bedside.

Authors:  Kamalakannan Palanichamy; Arnab Chakravarti
Journal:  Curr Opin Neurol       Date:  2009-12       Impact factor: 5.710

9.  The human secretome atlas initiative: implications in health and disease conditions.

Authors:  Kristy J Brown; Haeri Seol; Dinesh K Pillai; Binu-John Sankoorikal; Catherine A Formolo; Jenny Mac; Nathan J Edwards; Mary C Rose; Yetrib Hathout
Journal:  Biochim Biophys Acta       Date:  2013-04-19

10.  Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.

Authors:  Teresa E Peterson; Nathaniel D Kirkpatrick; Yuhui Huang; Christian T Farrar; Koen A Marijt; Jonas Kloepper; Meenal Datta; Zohreh Amoozgar; Giorgio Seano; Keehoon Jung; Walid S Kamoun; Trupti Vardam; Matija Snuderl; Jermaine Goveia; Sampurna Chatterjee; Ana Batista; Alona Muzikansky; Ching Ching Leow; Lei Xu; Tracy T Batchelor; Dan G Duda; Dai Fukumura; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.